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Antioxidant enzymeCancer cells utilize complex mechanisms to remodel their bioenergetic properties. We exploited the intrinsic
genomic stability of xeroderma pigmentosum C (XPC) to understand the inter-relationships between
genomic instability, reactive oxygen species (ROS) generation, and metabolic alterations during neoplastic
transformation. We showed that knockdown of XPC (XPCKD) in normal human keratinocytes results in
metabolism remodeling through NADPH oxidase-1 (NOX-1) activation, which in turn leads to increased ROS
levels. While enforcing antioxidant defenses by overexpressing catalase, CuZnSOD, or MnSOD could not block
the metabolism remodeling, impaired NOX-1 activation abrogates both alteration in ROS levels and
modiﬁcations of energy metabolism. As NOX-1 activation is observed in human squamous cell carcinomas
(SCCs), the blockade of NOX-1 could be a target for the prevention and the treatment of skin cancers. This
article is part of a Special Issue entitled: Bioenergetics of Cancer.ergetics of Cancer.
33000, France. Tel.: +33 557
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.
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Nucleotide excision repair (NER) is the major pathway for
repairing numerous types of DNA damage including helix-distorting
lesions produced mostly by ultraviolet (UV) radiation and bulky
lesions created by carcinogenic chemicals [1]. This system includes
two distinct sub-pathways: global genome repair (GGR), which
repairs DNA damage throughout the genome, and transcription-
coupled repair (TCR), which repairs DNA lesions within the
transcribed strand of active genes [2]. The pivotal role of NER is
demonstrated in xeroderma pigmentosum (XP), Cockayne syndrome,
and trichothiodystrophy, three dermatological diseases that manifest
skin photosensitivity [1]. Patients with XP exhibit extreme sensitivity
to solar UV light and have a disproportionately high incidence of skin
cancers [1,3]. XP patients are also at increased risk of developing
several types of internal malignancies before the age of 20 [4]. Thereare multiple subtypes of XP that have been deﬁned on the basis of
complementation groups and defective factors (XPA to XPG). Among
XP patients, XPC patients have a deﬁciency in the expression or
activity of XPC protein, an important DNA damage recognition protein
involved in GGR. Therefore, in these patients, that have proﬁcient TCR
and defective GGR, the cells accumulate mutations, notably UVB-
induced photoproducts such as cyclobutane pyrimidine dimers (CPD)
and 6-4 photoproducts (6-4 pp), in non-transcribed parts of the
genome, leading to neoplastic transformation [1]. It has also been
shown that XPC knockout mice have heightened predisposition to
many types of UV-induced and spontaneous cancers [5,6], indicating
that XPC plays a role in the removal of non-UV-related mutations as
well. Moreover, lymphocytes from XPC−/− mice accumulate sponta-
neous lesions in the hypoxanthine guanine phosphoribosyl transfer-
ase (HPRT) gene [7]. Interestingly, the most frequent mutations
observed in older mice (i.e. over one-year old) are G to T
transversions, which also result from oxidative processes [7],
suggesting a causative role for ROS. Measurement of ROS levels
indicated higher levels of ROS in XPC cells compared to control
ﬁbroblasts, suggesting a role of XPC in cell metabolism [8]. Here, we
assessed the effect of XPC downregulation on the modiﬁcation of ROS
levels and metabolism alteration. We found that downregulation of
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ROS levels, genomic and mitochondrial DNA oxidation, and altered
metabolism, which resembles the bioenergetic signature of most
cancer cells.
2. Materials and methods
2.1. Source and culture of cells
Normal human keratinocytes were isolated from normal human
skin in patients undergoing plastic surgery as previously described
[9,10]. Brieﬂy, fresh skin fragments were cut into 5 mm×5 mm pieces
and treated with trypsin–EDTA overnight at 4 °C, which allows for
separation of the epidermis from the dermis. Keratinocytes were
seeded at a concentration of 105 cells per cm2 in KGM medium
supplemented with hydrocortisone, epidermal growth factor, insulin
and bovine pituitary extract (all from Lonza, Walkersville, MD). The
mediumwas changed three times a week. When the cultures reached
70%–80% conﬂuence, the cells were detached with 10% trypsin–EDTA
and then resuspended in KGM medium.
2.2. Irradiation procedure and determination of CPD repair kinetics
Keratinocytes were irradiated at a dose of 40 mJ/cm2 using a
Biotronic device (Vilber Lourmat, Marne la Vallée, France) equipped
with a dosimeter. The UVB lamp emitted a continuous spectrum
between 280 and 380 nm (major peak at 312 nm) [11].
CPD repair efﬁciency was determined as already described [12].
Brieﬂy, exponentially growing asynchronous keratinocytes were
exposed to UVB. At different time intervals after irradiation, cells
were ﬁxedwith 4% formaldehyde for 10 min at room temperature and
then permeabilized overnight in cold 70% ethanol. Cells were then
resuspended in 0.5% Triton-X-100/2N HCl for 10 min at room
temperature. After washing with Tris–base 1 M (pH 10) and then
with PBS, keratinocytes were incubated overnight at 4 °C with 100 μl
PBS-TF (4% FBS/0.25% Tween-20/PBS) containing a 1:100 dilution of
anti-CPD (Kamiya Biomedical) antibodies. After washing twice with
PBS, cells were resuspended in 100 μl PBS-TF containing Alexa-FluorFig. 1. Vector constructs and analysis of the transduction efﬁciency. (A) Lentiviral vector cons
an internal cassette for the enhanced green ﬂuorescent protein (EGFP), catalase, CuZnSOD, o
R, and U5 are the LTR regions, with a deletion that includes the enhancer and the promoter fr
splice acceptor site, RRE is the rev-response element, cPPT is a nuclear import sequence, an
used to inhibit XPC, NOX-1, NOX-2, or red ﬂuorescent protein (RFP) expressions are shown533-coupled secondary antibody (1:200) for 1 h at room temperature.
Repair kinetics was then monitored using ﬂow cytometry (FACSCa-
libur, Becton Dickinson) to quantify the change in mean ﬂuorescence
over time.
2.3. Lentiviral vectors constructs and keratinocyte transduction
The different lentiviral vectors were constructed by inserting
catalase, CuZnSOD, and MnSOD cDNAs into the multiple cloning site
(MCS) of the TPW vector downstream of the human phosphoglycer-
ate kinase (hPGK) promoter as previously described (Fig. 1A) [10].
TPW was also used as the backbone for the construction of the
TEEHshXPC1, TEEHshXPC2, TEEHshNOX-1, TEEHshNOX-2 and
TEEHshRFP by replacement of the hPGK promoter by the EF-1α
promoter and inserting a cassette containing the H1 promoter
followed by shRNA sequences targeting either the XPC, NOX-1, or
NOX-2 mRNA or by a sequence targeting the dsRed (red ﬂuorescent
protein) mRNA, as control (shCtrl) (Fig. 1B). Lentiviral particles were
produced by transient transfection of 293T cells using a calcium
phosphate transfection technique as previously described [10].
Determination of the titer of each viral supernatant was performed
by assessing enhanced-green ﬂuorescent protein (EGFP) expression
by ﬂow cytometry and by enzyme-linked immunosorbent assays of
p24. For transduction, keratinocytes (5×105 cells per T25 ﬂasks) were
incubated for 24 h in complete medium. Prior to infection, the
medium was removed, and the cells were incubated with viral
supernatants for 24 h at 37 °C in the presence of 8 μg/ml of protamine
sulfate. After ﬁve days, the percentage of EGFP-positive cells was
determined by cytoﬂuorimetry [10].
2.4. Western blotting procedure
Western blotting was performed as previously described [10].
Brieﬂy, equal amounts of total protein were resolved by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) and electrophoreti-
cally transferred to PVDF membranes. The membranes were then
incubated overnight at 4 °C with a 1:1000 dilution of the anti-XPC
(GeneTex, San Antonio, TX), anti-MnSOD, anti-CuZnSOD (Santa Cruztructs used to overexpress EGFP, catalase, CuZnSOD, or MnSOD are shown. Vectors carry
r MnSOD driven by the promoter of human phosphoglycerate kinase gene (hPGK). ΔU3,
om U3. CMV is the cytomegalovirus promoter, SD is themajor splice donor site, SA is the
d WPRE is a regulatory element of woodchuck hepatitis virus. (B) Lentiviral constructs
. TEEHshRFP construct was used as the control shRNA (named shCtrl) plasmid.
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antibodies. After additional incubation with a 1:10,000 dilution of an
anti-immunoglobin horseradish peroxidase-linked antibody (Vector
Laboratories, Burlingame, CA) for 1 h, blots were developed using the
chemiluminescence ECL reagent (Amersham, Piscataway, NJ).
2.5. Measurement of glucose consumption and lactate production
Glucose consumption and lactate production was measured using
colorimetric assay kits according to the manufacturer (both from
BioVision, Mountain View, CA). Brieﬂy, two days before each time
point, the medium was changed. At indicated time points, 1 mL of
medium was collected for the measurement of glucose and lactate
levels. Cells in each plate were then harvested, counted, and the total
protein concentration was measured by the BCA kit reagent (Pierce,
Bezons, France). The levels of glucose uptake and the lactate
production were normalized per mg of protein at the indicated time
points. The results were then standardized to the shCtrl levels and
were expressed as the average percentage of shCtrl levels at each time
point.
2.6. Measurement of endogenous and mitochondrial ATP production
The amount of intracellular ATP was measured by a luciferin/
luciferase-based assay. In brief, the cells were trypsinized, rinsed with
PBS, and lysed with 0.2 mL of cell lysis reagent. ATP concentrations in
the cell lysates were quantiﬁed using an ATP bioluminescence assay
kit HSII (Roche Applied Science, Indianapolis, IN) in accordance with
the manufacturer's instructions. A standard curve for ATP concentra-
tion was plotted using standard ATP solution. ATP levels were
calculated and normalized to protein lysate concentrations. To assess
the ATP levels produced by mitochondria, the cells were incubated
with 1 mM of iodoacetate for 5 min before they were trypsinized.
Iodoacetate is an inhibitor of glycolysis since it inhibits glyceralde-
hyde 3-phosphate dehydrogenase. Therefore, ATP generation by the
cells following this treatment must be a consequence of oxidative
phosphorylation (OXPHOS) activity. In addition, the extent of
mitochondrial ATP production was veriﬁed by using antimycin A.
After treatment, the cells were subjected to the same procedures as
the untreated cells.
2.7. Complex IV (cytochrome c-oxidase) activity
Cytochrome c-oxidase activity was determined spectrophotomet-
rically with cytochrome c (II) as the substrate. The oxidation of
cytochrome c was monitored at 550 nm at 30 °C using a double-
wavelength Xenius spectrophotometer from SAFAS (Monaco) and
standardized reproducible methods as described by Bernard et al.
[13].
2.8. RNA extraction and quantitative real-time RT-PCR
Total cellular RNA was extracted using TRIzol® (Invitrogen, CA)
according to the manufacturer's instructions. Total cellular RNA (2 μg)
was reverse transcribed at 42 °C for 60 min using the 1st Strand cDNA
synthesis kit (Roche Applied Science). Real-time RT-PCR was carried
out for NOX-1, NOX-2, and GAPDH. The reactions were cycled 40
times after initial polymerase activation (50 °C, 2 min) and initial
denaturation (95 °C, 15 min) using the following parameters: dena-
turation at 95 °C for 15 s, annealing at 58 °C for 45 s, and extension at
60 °C for 1 min. A ﬁnal fusion cycle (95 °C, 30 s; 60 °C, 30 s; 95 °C,
30 s) terminated these reactions. Forward and reverse primers for
NOX-1 were 5′-CCGCACACTGAGAAAGCAAT-3′ and 5′-CCGGA-
CAATTCCACCAAT-3, and for GAPDH were 5′-TCATTGACCTCAACTA-
CATGGTTT-3′ and 5′-GGCATGGACTGTGGTCATGAG TC-3′. The analysis
of NOX-2mRNAwas performed by two-step real time RT-PCR. For theﬁrst-round PCR, forward and reverse primers were 5′-GGAAACCCTCC-
TATGACTTGG-3′ and 5′-GCCCATCAACCGCTATCTTA-3′ giving a 380 bp
product. For the second-round nested PCR, forward and reverse
nested primer were 5′-TCATCACCAAGGTGGTCACT-3′ and 5′-
GGGCGGATGTCAGTGTAAAA-3′ giving a 210 bp product.
2.9. Measurement of intracellular ROS
The intracellular production of ROS was assessed using a CM-
H2DCF-DA [5-(and-6)-chloromethyl-2′,7′-dichlorodihydroﬂuorescein
diacetate, acetyl ester] cytoplasmic probe or the MitoSOX™ red
mitochondrial superoxide indicator (both from Molecular Probes,
Invitrogen) [10]. Brieﬂy, after addition of CM-H2DCF-DA (5 μM) or
MitoSOX (5 μM), the cells were incubated for 15 min at 37 °C in the
dark. While CM-H2DCF is oxidized by cytoplasmic ROS to the highly
green ﬂuorescent CM-DCF [5-(and-6)-chloromethyl-2′,7′-dichloro-
ﬂuorescein] compound, MitoSOX is targeted to the mitochondria and
oxidized by superoxide to a red ﬂuorescence component. After two
washes with PBS, the cells were detached by trypsin–EDTA and
immediately analyzed by ﬂow cytometry. Ten thousand individual
data points were collected for each sample.
2.10. Determination of catalase, CuZnSOD and MnSOD activities
All these assays were performed as previously described [10] using
the SOD assay kit-WST (Dojindo Molecular Technologies, Gaithers-
burg, MD) and the Amplex Red Catalase Assay Kit (Molecular Probes,
Invitrogen).
2.11. Detection of NADPH Oxidase activity in cell-free system
NADPH oxidase activity was measured in plasma membranes
obtained from skin specimens. Brieﬂy, skin specimens were treated
with 3 mM diisopropylﬂuorophosphate for 15 min on ice and
resuspended in 1 mL of phosphate-buffered saline containing 1 mM
phenylmethylsulfonyl ﬂuoride, 2 μM leupeptin, 2 μM pepstatin, and
10 μM 1-chloro-3-tosylamido-7-amino-2-heptanone. Following son-
ication, the homogenate was centrifuged at 1000 ×g for 15 min at
4 °C. The supernatant was withdrawn and centrifuged 12,000 ×g. The
supernatant was centrifuged at 100,000 ×g for 1 h at 4 °C. The
supernatant was referred to as the cytosol, and the pellet consisting
of crudemembranes was resuspended in the same lysis buffer. Plasma
membrane were added to a reaction mixture containing 20 mM
glucose, 20 μM GTPγS, 5 mM MgCl2, and arachidonic acid in a ﬁnal
volume of 100 μl. After incubation for 10 min at 25 °C, the oxidase
activation was initiated in the presence of 100 μM cytochrome c and
150 μM NADPH. The speciﬁcity of the production was checked by
adding 50 μg/ml superoxide dismutase to stop the kinetic reduction as
well as by pretreatment with DPI. The reduction of cytochrome c is
monitored by the increase of cytochrome c absorbance at 550 nm.
2.12. Morphological studies of mitochondria and morphometry
To observe the mitochondria network by ﬂuorescence confocal
microscopy, keratinocytes grown on 6-well plates were incubated
with MitoTracker (Molecular Probes) 150 nM for 20 min at 37 °C for.
After two washes in PBS, the cells were observed and photographed
under a FluoView laser scanning inverted microscope (Nikon). The
morphology of the mitochondrial network was studied by using
Mitotracker Green (Invitrogen), the objective used was a Plan
Apochromat 60.0X/1.4/0.21 oil spring loaded. The images were
acquired using the EZ-C1 Gold Version 3.2 build 610, as follow
(at 37 °C): the pinhole was set at 33.3 μm and the image size was
1024×1024. The step size was 0.5 μm, and the acquisition time of the
Z-series set at 10 frames per second. The number of images was
adapted to the width of each cells determined individually. The
Fig. 2. Effects of XPC downregulation on intracellular ROS levels and genomic and
mitochondrial DNA oxidation. (A) Efﬁciency of XPC silencing was checked by western
blotting analysis. (B) To evaluate the functional effect of XPC silencing on DNA repair,
keratinocytes were harvested at different times after UVB-irradiation and levels of CPD
were analyzed by ﬂow cytometry following ﬂuorescent immunostaining with the
corresponding speciﬁc antibody. The percentage of CPDs remaining at different time
points after irradiation was evaluated and the results are expressed as the mean±SD of
3 independent experiments. (C) ROS levels in shCtrl- and shXPC-transduced cells were
measured by ﬂow cytometry using cytoplasmic- and mitochondrial-speciﬁc probes on
the indicated days after transduction. The ROS level in the shCtrl-transduced cells was
arbitrarily set to 100. Results are expressed as the mean±SD of three independent
experiments. *pb0.05 for shXPC-transduced cells vs shCtrl-transduced cells at the
indicated time points. (D) Genomic andmitochondrial DNA oxidation were assessed by
quantiﬁcation of 8-oxodG levels in nuclear genome and mtDNA of different cells.
Results are expressed as ng of 8-oxodG per μg of DNA. Results are expressed as the
mean±SD of three independent experiments. *pb0.05 for shXPC-transduced cells vs
shCtrl-transduced cells at the indicated time points. shCtrl, keratinocytes transduced
with control shRNA; shXPC, keratinocytes transduced with shXPC.
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Imaris Software (Bitplane). Fifty cells per experimental condition
were selected randomly on 5 different images, and the analysis of
mitochondrial tubule length was performed with the morphometric
software “Morpho. Pro” by Explora Nova (France). It allowed to select
automatically the region of interest (i.e. the mitochondrial tubule),
and to calculate the length occupied by the selected pixels. In each
cell, 25 tubules were measured. The tubules were divided in four
categories based on their size, those b5, between 5 and 10, between
10 and 20, and those N20 μm. Results expressed as average percentage
of size distribution ± SD of three independent experiments.
2.13. Quantiﬁcation of 8-oxodG in nuclear and mitochondrial DNA
8-oxodG adducts in nuclear and mitochondrial DNA were
quantiﬁed using an enzyme-linked immunoabsorbent assay kit
(Trevigen, Gaithersburg, MD) in accordance with the manufacturer's
instructions. Brieﬂy, following nuclear and mitochondrial DNA
isolation, 1 μg of DNA was incubated with anti-8-oxodG antibody
overnight at 4 °C. The samples were then added to 96-well microtiter
plates containing bound albumin:8-oxodG adducts and incubated at
room temperature for 2 h. The plate was then washed and incubated
with a peroxidase-coupled secondary antibody for 1 h. After washing,
tetramethybenzidene substrate was added to eachwell and incubated
for 15 min in the dark. After addition of the stop solution, absorbance
has been measured at 450 nm. Results were calculated based on a
standard curve that was run simultaneously.
2.14. Statistics
Statistical analyses were performed using one-way ANOVA tests,
followed by post-hoc Tukey's tests. A p-value ofb0.05 was considered
signiﬁcant. Results are presented as means±SD.
3. Results
3.1. XPC downregulation results in increased oxidative stress in both
nuclear and mitochondrial compartments
To determine the effect of XPC expression on ROS levels, the XPC
protein expression was ﬁrst inhibited using lentivirus-mediated
expression of short hairpin RNA (shRNA) against XPC (Fig. 1B). To
rule out “off target” effects of shXPC, all experiments were performed
with two distinct shRNAs against XPC. Both shXPCs stably inhibited
more than 92% of XPC expression in keratinocytes (Fig. 2A). To test the
functional effect of XPC downregulation on DNA repair, we evaluated
the repair kinetics of CPDs, the most frequent types of photolesions,
which are removed primarily by NER [14]. While 91±7% of CPDs in
shCtrl-transduced cells were gradually removed by 40 h following
UVB irradiation, the rate of CPDs repair in keratinocytes transduced
with shXPC1 or shXPC2 was 17±5% and 20±4%, respectively
(Fig. 2B). Since both shRNA had similar effects, hereafter only the
results of shXPC1 have been shown.
We then characterized the role of XPC silencing on ROS
production. To this end, we measured the cytoplasmic and mito-
chondrial steady-state levels of ROS using CM-H2DCF-DA and
MitoSOX probes, respectively (Fig. 2C). XPC silencing resulted in a
signiﬁcant increase in cytoplasmic ROS level over time in comparison
to control cells. In contrast, a moderate, but signiﬁcant, decrease in
mitochondrial ROS level was found ﬁve days after XPC down-
regulation, followed by a gradual increase that peaked 30 days post-
transduction.
Since ROS can lead to oxidative DNA damage, we determined the
level of genomic and mitochondrial DNA (mtDNA) oxidation using an
antibody directed against 7,8-dihydro-8-oxoguanine (8-oxodG)
(Fig. 2D). Results showed that 8-oxodG increased in the nucleargenome and in the mtDNA after XPC silencing in a time-dependent
manner. These data indicate that XPC silencing-induced ROS
generation results in increased oxidative stress in both the nuclear
and mitochondrial compartments.
3.2. Overexpression of antioxidant enzymes does not block ROS
generation induced by XPC silencing
To determine the origin of the ROS, we further investigated the
role of antioxidant enzymes on ROS levels. To this end, we used
overexpression of catalase, CuZnSOD, or MnSOD (Fig. 1A). First of all,
the efﬁciency of keratinocyte transduction with various vectors
expressing EGFP, catalase, CuZnSOD, or MnSOD was determined by
assessing EGFP-positive cell percentage and by measuring catalase-,
MnSOD-, and CuZnSOD-speciﬁc activities and proteins (Fig. 3A, B).
The percentage of EGFP-positive cells, determined by cytoﬂuorimetry
ﬁve days post-transduction, was between 85% and 95%. The increase
in the amount of catalase, MnSOD, and CuZnSOD proteins was assayed
by western blotting (Fig. 3A). Corresponding enzyme activities were
measured after ﬁve days of culture (Fig. 3B). In the cells transduced by
catalase, CuZnSOD, or MnSOD the activity of each enzyme was 6.5-
fold for catalase, 7.4-fold for CuZnSOD, and 5.9 fold for MnSOD
compared to Ctrl cells. Transduction of cells by catalase-expressing
vector did not affect SOD activity or vice-versa. Overexpression of
Fig. 3.Overexpression of Catalase, MnSOD, or CuZnSOD has no effect on XPC-silencing-induced ROS generation. (A, B) Transduction efﬁcacywas checked bywestern blotting analysis
(A) and also by measuring the speciﬁc activity of each antioxidant enzyme in the keratinocytes (B) as described in the Materials and methods section. (C) Intracellular ROS levels
were measured in keratinocytes transduced with shCtrl, shXPC, catalase, CuZnSOD and/or MnSOD, on different days following transduction using CM-H2DCF-DA, the cytoplasmic
probe, or MitoSOX, the mitochondrial probe by ﬂow cytometry. Data are assessed as shown on the top of the planes and expressed as the mean±SD of 3 independent experiments.
(D) Genomic and mitochondrial DNA oxidation were assessed by quantiﬁcation of 8-oxodG levels in nuclear genome and mtDNA of different cells. Results are then assessed as
shown on the top of the panels and expressed as the mean±SD of three independent experiments.
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state levels of endogenous ROS, but could not block ROS generation
induced by XPC silencing (Fig. 3C), suggesting that enforcing the
antioxidant defenses is not sufﬁcient to inhibit XPC knockdown-
induced ROS generation. Whereas the overexpression of CuZnSOD
yielded limited effects on XPC silencing-induced 8-oxodG formation,
the overexpression of catalase or MnSOD resulted in a signiﬁcant
reduction of 8-oxodG accumulation in mtDNA (Fig. 3D). Nonetheless,
the overexpression of these antioxidant enzymes could not com-
pletely block 8-oxodG accumulation in the nuclear genome and
mtDNA.
3.3. Activation of NADPH oxidase-1 is responsible of ROS generation in
XPCKD
Under physiological conditions, ROS are generated by mitochon-
dria via enzyme complexes involved in oxidative phosphorylation.
Numerous cytosolic enzymes including cyclooxygenase, nitric oxidesynthase, xanthine oxidase, and the plasmamembrane-bound NADPH
oxidase can also generate ROS. To determine the origin of XPC
silencing-induced cytoplasmic ROS generation, cells were treated
with the various inhibitors of cytosolic ROS-generating enzymes: NG-
Monomethyl-arginine (NMMA, 100 μM), an inhibitor of nitric oxide
synthase; allopurinol (100 μM), an inhibitor of xanthine oxidase;
hydroxyurea (1.5 mM), an inhibitor of ribonucleotide reductase;
indomethacin (100 μM), an inhibitor of cyclooxygenase (COX); and
diphenyl-iodonium (DPI, 2.5 μM), an inhibitor of cytoplasmic NAPDH
oxidase. While treatment of cells with the inhibitor of nitric oxide
synthase, xanthine oxidase, ribonucleotide reductase, or COX had no
effect on ROS generation after XPC downregulation, DPI treatment
completely blocked the increase in cytoplasmic ROS levels (Fig. 4A),
suggesting an obvious role for NADPH oxidase in ROS production.
NADPH oxidase consists of six hetero-subunits that, when
activated, associate to form an active enzyme complex generating
O2− from oxygen using NADPH as electron donor [15]. The catalytic
subunit of this complex, NOX, has seven homologous members
Fig. 4. Inhibition of NOX-1 expression blocks the effect of XPC downregulation on ROS levels. (A) Cytoplasmic and mitochondrial ROS levels were measured in shXPC transduced
cells. The effect of different inhibitors on XPC silencing-induced ROS production was assessed as shown at the top of the panels. (B, C) Transduction efﬁcacy was checked by western
blotting analysis (B) and also by measuring the mRNA expression of NOX-1 and NOX-2 in the keratinocytes (C). (D) The effect of NOX-1 and NOX-2 downregulation on XPC
silencing-induced cytoplasmic and mitochondrial ROS production was assessed as shown on the top of the panels. Results are expressed as the mean±SD of 3 independent
experiments. (E) Genomic and mitochondrial DNA oxidation were assessed by quantiﬁcation of 8-oxodG levels in nuclear genome and mtDNA of different cells. Results are then
assessed as shown on the top of the panels and expressed as the mean±SD of three independent experiments.
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among NOX isozymes, NOX-1 and NOX-2 are expressed in keratino-
cytes [16,17]. NOX proteins are involved in host defense, post-
translational processing of proteins, cell signaling, regulation of gene
expression, and cell differentiation [15]. To further characterize the
role of NADPH oxidase in ROS production in XPCKD, NOX-1 and NOX-2
protein expression was inhibited using lentivirus-mediated expres-
sion of shRNA against NOX-1 and NOX-2 (Fig. 1B). shNOX-1 and
shNOX-2 stably inhibited more than 90% of NOX-1 and NOX-2 protein
and mRNA expression in keratinocytes, respectively (Fig. 4B, C). We
next examined the effects of NOX-1 or NOX-2 downregulation on ROS
levels in XPCKD cells. Our results indicated that NOX-2 has no
involvement in ROS generation in XPCKD (Fig. 4D). In contrast, NOX-
1 downregulation completely blocked both cytoplasmic and mito-
chondrial ROS generation in XPCKD (Fig. 4D). Our data further
indicated that downregulation of NOX-1 (but not NOX-2) blocked
the oxidative effects of XPC silencing on genomic and mitochondrial
DNA (Fig. 4E). Taken together, our results demonstrate that NADPH
oxidase-1 activation plays an essential role in the XPC-silencing
induced oxidative stress.3.4. XPC downregulation results in mitochondrial bioenergetics
deﬁciency through NOX-1 activation
Since one of the mechanisms explaining metabolism remodeling
(the Warburg effect) during tumorigenesis is oxidative stress due to
elevated ROS levels [18–21], we wondered whether increased ROS
levels in XPCKD cells results in metabolism alteration. To test this
concept, we ﬁrst measured glucose consumption and lactate produc-
tion in shCtrl- and shXPC-transduced keratinocytes over 30 days
following transduction. Results revealed that XPCKD cells exhibited
lactic acidosis at 20 and 30 days post-transduction (Fig. 5A, B). ATP
levels were similar in shCtrl- and shXPC-transduced keratinocytes on
different days post-transduction (Fig. 5C), although decreased ATP
production occurred ﬁve days after shXPC transduction. To determine
whether XPCKD are more dependent on glycolysis or OXPHOS for ATP
generation, the ATP level was measured in the presence of
iodoacetate, an inhibitor of glycolysis. ATP levels were decreased to
a greater extent in the iodoacetate-treated XPCKD cells as compared to
control keratinocytes on days 20 and 30 (Fig. 5D). The ATP produced
by the mitochondrion in entire cells results from the oxidation of the
pyruvate generated by glycolysis, and the oxidation of several other
fuels, such as glutamine, glycine, alanine, proline and ketone bodies
which do not require glycolysis [22]. Therefore, iodoacetate treatment
will block the synthesis of the ATP linked to glycolysis both directly
and indirectly (i.e. through the oxidation of pyruvate by OXPHOS).
Yet, in most rapidly growing cancer cells, the pyruvate generated by
glycolysis is mainly transformed in lactate by the LDH and very little
enters the Krebs cycle [23]. In our study, reduction of the total ATP
levels measured in the presence of iodoacetate in XPCKD cells indicates
a higher dependence of these cells on glycolysis to generate ATP, both
directly and indirectly. Finally, to determine whether OXPHOS activity
is affected by XPC downregulation, we assessed the complex IV
activity. Results showed that the complex IV activity also diminished
following XPC downregulation (Fig. 5E).
We further investigated the role of ROS in metabolism remodeling
using XPCKD cells overexpressing the antioxidant enzymes, catalase,
CuZnSOD, or MnSOD, as well as cells with downregulation of NOX-1
or NOX-2. Results revealed that neither the overexpression of
antioxidants enzymes, nor the downregulation of NOX-2 abrogated
XPC silencing-induced increased glucose uptake, elevated lactate
production, and decreased ATP generation by mitochondria. In
contrast, the downregulation of NOX-1 in XPCKD restored glucose
consumption (Fig. 5A), lactate production (Fig. 5B), and mitochon-
drial ATP production (Fig. 5C, D).Mitochondrial morphology is linked to bioenergetics and changes
in the state of mitochondrial energy result in structural alterations of
the mitochondrial network [24]. To determine whether XPC down-
regulation affects mitochondrial network morphology, cells were
stained with a MitoTracker probe. Normal keratinocytes demonstrat-
ed an interconnected network located predominantly around the
nucleus, while XPCKD displayed a larger tubular mitochondrial
network more dispersed throughout the cytoplasm (Fig. 6A, B).
Interestingly, NOX-1 downregulation, but not the overexpression of
antioxidant enzymes or NOX-2 downregulation, blocked XPC silenc-
ing-induced alterations in mitochondrial network morphology
(Fig. 6B). A similar dispersion of the mitochondrial network occurs
in situations of moderate OXPHOS deﬁciency triggered by pathogenic
mutations in complex I [25,26] or by pharmacological inhibitions of
the mitochondrial respiratory chain [27,28].
Taken together, our results demonstrate that XPC silencing in
normal human keratinocytes leads to the alteration of metabolism,
which resembles the metabolic signature of most cancer cells. These
results also indicate that variations in glycolysis and mitochondrial
metabolism following XPC downregulation are dependent on the
upregulation of NADPH oxidase-1.
3.5. NOX-1 expression is increased in skin SCC
Since we have already shown that XPC silencing in normal human
keratinocytes drives the formation of SCC [29] and the activation of
the NOX family has been shown in many cancer cells [19], we sought
to investigate the NOX activity in skin tumors. To this end, we ﬁrst
assessed the activity of NADPH oxidase in skin specimens from
healthy individuals (HNS; n=15), foreskin (n=15), human SCC
(HSCC; n=15), and human BCC (HBCC; n=15) (Fig. 7A). Results
showed higher NADPH oxidase activity in HSCC compared to HNS or
foreskin.
To conﬁrm the in situ observation, the mRNA expression of NOX-1
and NOX-2 in SCC was analyzed. Interestingly, while the mRNA
expression of NOX-2 in HSCC and HNS or foreskin did not show
substantial differences, NOX-1 expression was signiﬁcantly higher in
HSCC compared to HNS or foreskin (Fig. 7B), suggesting that the
blocking of NOX-1 activation might offer an interesting target for the
prevention and the treatment of human SCC.
4. Discussion
Bioenergetics studies of cancer cells led OttoWarburg to show that
aerobic glycolysis (up to pyruvate/lactate) is generally, but not
exclusively, increased in malignant cells and that these cells are
constitutively more dependent on the glycolytic pathway for ATP
generation, even under oxygen-sufﬁcient conditions [30]. Warburg
proposed that a respiratory deﬁciency might facilitate neoplastic
transformation [30]. Current data revealed that a large number of
cancer cell lines have a higher rate of glycolysis, an increased rate of
glucose transport, increased pentose phosphate pathway activity,
decreased numbers of mitochondria, and a reduction inmitochondrial
OXPHOS proteins and activities [18,20,31–33]. Mechanistic studies
have linked those metabolism alterations to somatic mutations in
mtDNA, increased ROS, adaptation to tissue hypoxia [18–21],
activation of oncogenes and/or inactivation of tumor suppressors
(TP53, HIF-1α, c-MYC), as well as deregulation of PI3K/AKT, which
inﬂuence the glycolytic ﬂux through the regulation of different factors
(reviewed in [34]).
However, the etiologic relationship between genomic mutations,
the Warburg effect, and increased ROS levels in tumor induction
remains unclear [19,20,35]. We speculated that XPC-deﬁcient cells,
which have a heightened predisposition to malignant transformation
and are capable of accumulating the mutations in the non-transcribed
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Fig. 6. XPC silencing triggers modiﬁcation in mitochondrial network modiﬁcation. (A) The mitochondrial network morphology in shCtrl- and shXPC-transduced keratinocytes was
determined by microscopy using Mito Tracker. (B) Length of mitochondrial tubules was measured in 50 cells (25 mitochondrial tubules per cell) per condition. Results are expressed
as the average percentage of mitochondrial tubule size distribution±SD of 3 independent experiments. *pb0.05 for different transduced cells vs shCtrl-transduced cells.
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genomic mutations and modiﬁed cellular bioenergetics, and ROS.
We showed that XPC silencing results in NOX-1 activation and
subsequently increased cytoplasmic ROS levels. Cytoplasmic ROS
generation will consequently lead to the enhanced oxidation of
nuclear and mitochondrial DNA, followed by the induction of
mitochondrial ROS in an ampliﬁcation loop of DNA damage↔ ROS
(Fig. 8). It is likely that OXPHOS deﬁciency could amplify oxidative
mtDNA damage. In fact, our results show that 8-oxodG accumulation
in mtDNA deletions increase concomitantly with decreased mito-
chondrial metabolism. Consistent with this, Ishii et al. [36] reported
that a mutation in the cytochrome b gene of Caenorhabditis elegans
enhances oxidative stress and shortens lifespan, indicating that a
defect in the mitochondrial respiratory system can lead to increased
oxidative damage. Similarly, inhibition of OXPHOS by deleting a
mitochondrial adenine nucleotide translocase (ANT) augments ROS
levels and deletions and rearrangements in mtDNA [37]. This model
also explains why we obtain increased mitochondrial 8-oxodG levelsFig. 5. XPC silencing drives metabolism remodeling via NOX-1 activation. Glucose consumptio
produced by mitochondria (D), and the relative activity of complex IV of the mitochondrial r
different vectors as shown on the top of the panels. The glucose uptake, lactate production, a
set to 100% at each time point. The results were then compared to the shCtrl and are express
for different transduced cells vs shCtrl-transduced cells.before the detection of increased mitochondrial ROS. In fact,
cytoplasmic ROS, especially H2O2 which cannot be detected by
Mitosox, pass through the mitochondrial membrane and result in
the induction of oxidativemtDNA damage, i.e. 8-oxodG. It is likely that
NOX activation-induced increased cytoplasmic ROS leads to enhanced
oxidation of nuclear and mitochondrial DNA, followed by alterations
in mitochondrial bioenergetics. Interestingly, inhibition of NOX-1
activation, thanks to NOX-1 knockdown or treatment with DPI,
inhibits the Warburg effect in XPCKD, indicating that NOX activation-
induced ROS generation is the cause of the Warburg effect in XPCKD.
One of the proposed mechanisms explaining theWarburg effect is the
occurrence of a deﬁciency in mitochondrial respiration during cell
growth due to somatic mutations in mtDNA or increased oxidative
stress [18,19]. Mutations in mtDNA have consistently been found to
correlate with the 8-OxodG content in mtDNA [38]. Elevated ROS
generation due to environmental insults (i.e., UV irradiation [39,40],
ionizing radiation [41]) or by xenobiotics [39,40] has also been shown
to lead to mtDNA deletions. Intraperitoneal injection of doxorubicinn (A), lactate production (B) as well as the total endogenous ATP level (C) and ATP level
espiratory chain (E) were measured at the indicated time points after transduction with
nd the total endogenous and mitochondrial ATP levels by shCtrl-transduced cells were
ed as the average percentage of shCtrl±SD of three independent experiments. *pb0.05
Fig. 7. Overexpression of NOX-1 in SCC. (A) NADPH oxidase activity was measured in
human skin specimens obtained from healthy individuals (HNS), foreskins, human SCC
(HSCC) and human BCC (HBCC). Measurements of individual samples and mean values
are shown. (B) The mRNA expression levels of NOX-1 and NOX-2 were analyzed by real
time RT-PCR in mention samples.
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mtDNA in in vivo systems [42]. Furthermore, a decreased antioxidant
defense system in themitochondria of MnSOD knockout mice leads toFig. 8. A model outlining cellular responses to XPC downregulation. Lentivirus-mediated XP
the activation of NOX-1. Cytoplasmic ROS generation will consequently increase, leading to
mtDNA damage, enhancement of mitochondrial ROS production, and alterations in mitochoenhanced oxidative damage and reduced OXPHOS activity [43]. Our
results illustrate that overexpression of catalase or MnSOD in XPCKD
cells results in a signiﬁcant reduction of 8-oxodG accumulation in
mtDNA, but could not completely abrogate XPC silencing-induced
cytoplasmic and mitochondrial ROS generation and subsequent
oxidation of nuclear and mitochondrial DNA (Fig. 3).
Consistent with our data supporting that XPC silencing results in
oxidative damage, XPC-deﬁcient cells have been shown to be more
sensitive to oxidative stress [44,45]. XPC knockout transgenic mice
studies reveal the high frequency of the spontaneous lung tumors and
hepatocellular adenomas [46]. Spontaneous mutation frequencies in
the HPRT gene are 30-fold higher in the spleen of XPC−/− mice
compared to normal mice and the majority of these mutations result
from oxidative damage [7]. Furthermore, the predisposition to UV-
induced skin cancer in XPC−/−mice has been shown to be enhanced if
these animals are also heterozygous for Apex [47], a gene coding the
apurinic/apyrimidinic endonuclease which is a key enzyme in the
base excision repair, required for the repair of spontaneous base
damage that arises as a result of oxidative damage to DNA.
Interestingly, the kinetics of cancer induction in XPC−/− mice that
are heterozygous additionally for both p53 and Apex is indistinguish-
able from that in XPC−/− mice heterozygous for just p53 [47],
suggesting that the enhanced predisposition to skin cancer in XPC−/−
Apex+/− animals could result from oxidative stress-induced loss of
p53 activity.
In conclusion, we demonstrated that NOX-1 activation induced by
XPC silencing can result in ROS generation and the Warburg effect.
This effect may be relevant to the pathophysiology of common skin
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